Showing results (51-60 of 138) with videos related to
Sort By:
Pageof 14
Genes|May 28, 2022
Prominent Follicular Keratosis in Multiple Intestinal Atresia with Combined Immune Deficiency Caused by a TTC7A Homozygous MutationAndrea Diociaiuti, Roberta Caruso, Silvia Ricci, et al.Pediatric Radiology|December 10, 2016
Magnetic resonance imaging patterns of treatment-related toxicity in the pediatric brain: an update and review of the literatureMaria Camilla Rossi Espagnet, Luca Pasquini, Antonio Napolitano, et al.Journal of Medicinal Chemistry|September 1, 2006
Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeletonRosaria Gitto, Roberta Caruso, Benedetta Pagano, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytesIlaria Peluso, Massimo Claudio Fantini, Daniele Fina, et al.The Journal of Physical Chemistry. A|October 28, 2020
Understanding Covalent versus Spin-Orbit Coupling Contributions to Temperature-Dependent Electron Spin Relaxation in Cupric and Vanadyl PhthalocyaninesAlec H Follmer, Ryan D Ribson, Paul H Oyala, et al.Biochemical Pharmacology|November 6, 2007
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acidCarmine Stolfi, Daniele Fina, Roberta Caruso, et al.Archiv Der Pharmazie|June 20, 2006
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agentsLaura De Luca, Rosaria Gitto, Maria Letizia Barreca, et al.European Journal of Cancer (Oxford, England : 1990)|August 18, 2006
5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell deathDaniele Fina, Luigi Franchi, Roberta Caruso, et al.Molecular Cancer Therapeutics|August 6, 2011
2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expressionCarmine Stolfi, Roberta Caruso, Eleonora Franzè, et al.Carcinogenesis|May 23, 2008
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phaseCarmine Stolfi, Daniele Fina, Roberta Caruso, et al.Pageof 14